PS1
/ Pharmasaga
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 08, 2026
Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects
(clinicaltrials.gov)
- P1 | N=75 | Completed | Sponsor: Pharmasaga Co. Ltd. | Recruiting ➔ Completed | Trial completion date: Jul 2025 ➔ Jun 2026 | Trial primary completion date: Jul 2025 ➔ Apr 2026
First-in-human • Trial completion • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
April 15, 2024
Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects
(clinicaltrials.gov)
- P1 | N=64 | Recruiting | Sponsor: Pharmasaga Co. Ltd. | Trial completion date: Jun 2024 ➔ Jul 2025 | Trial primary completion date: Jun 2024 ➔ Jul 2025
Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
December 14, 2023
Safety, Pharmacokinetics, and Food Effect of PS1 in Subjects
(clinicaltrials.gov)
- P1 | N=64 | Recruiting | Sponsor: Pharmasaga Co. Ltd. | Not yet recruiting ➔ Recruiting | Trial completion date: Dec 2023 ➔ Jun 2024 | Trial primary completion date: Dec 2023 ➔ Jun 2024
Enrollment open • Trial completion date • Trial primary completion date • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 3
Of
3
Go to page
1